Equities

Allergy Therapeutics PLC

AGY:LSE

Allergy Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10.90
  • Today's Change-1.00 / -8.40%
  • Shares traded512.78k
  • 1 Year change72.47%
  • Beta1.4518
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Forecasts data is unavailable for this security.

Consensus recommendation

  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy1
Outperform0
Hold0
Sell0
Strong Sell0

Share price forecast

The one analyst offering a 12 month price target expects Allergy Therapeutics plc share price to rise to 13.00 in the next year from the last price of 10.90.
High19.3%13.00
Med19.3%13.00
Low19.3%13.00

Earnings history & estimates

Allergy Therapeutics plc reported annual 2025 losses of -0.84 per share on Dec 11, 2025.
Average growth rate-26.31%
More ▼

Revenue history & estimates

Allergy Therapeutics plc had revenues for the full year 2025 of 55.04m. This was 0.28% below the prior year's results.
Average growth rate-9.92%
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.